1. Home
  2. BBAR vs TLX Comparison

BBAR vs TLX Comparison

Compare BBAR & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banco BBVA Argentina S.A. ADS

BBAR

Banco BBVA Argentina S.A. ADS

HOLD

Current Price

$21.28

Market Cap

4.1B

Sector

Finance

ML Signal

HOLD

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$11.23

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBAR
TLX
Founded
1886
2015
Country
Argentina
Australia
Employees
N/A
1184
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.6B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
BBAR
TLX
Price
$21.28
$11.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$17.00
$21.13
AVG Volume (30 Days)
714.8K
212.0K
Earning Date
05-20-2026
08-19-2026
Dividend Yield
2.04%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$18.32
N/A
Revenue Next Year
$11.04
N/A
P/E Ratio
$26.78
$150.33
Revenue Growth
N/A
N/A
52 Week Low
$7.76
$6.28
52 Week High
$22.47
$16.85

Technical Indicators

Market Signals
Indicator
BBAR
TLX
Relative Strength Index (RSI) 61.75 55.49
Support Level $17.03 $9.46
Resistance Level $21.92 $11.38
Average True Range (ATR) 1.13 0.28
MACD -0.09 0.06
Stochastic Oscillator 71.69 52.96

Price Performance

Historical Comparison
BBAR
TLX

About BBAR Banco BBVA Argentina S.A. ADS

Banco BBVA Argentina SA is a banking services provider in Argentina. It provides financial assistance to large corporations, small and medium-sized companies, as well as individuals. It bank provides services through retail, corporate, investment banking, and Small and medium-sized companies divisions. Through the retail banking segment, it provides banking products and services to individuals, corporate banking deals with services to corporates, and the small and medium-sized companies segment focuses on foreign trade, agricultural business, and digital products.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: